In humans, SEL1L ERAD has been reported to be involved in children’s neurodevelopmental disorders, such as developmental delay, intellectual disability, microcephaly, facial dysmorphisms, hypotonia, and/or ataxia (40). Here, SEL1L is linked to Ataxia.